BBBY vs RPRX
BBBY (BBBY) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
BBBY (BBBY) common stock.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
BBBY does not have a complete income-statement cache yet.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
BBBY currently screens at market cap $0. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the BBBY and RPRX stock pages for the full models.
Not investment advice.